Literature DB >> 11092708

DOTS and DOTS-Plus: what's in a name.

K S Lambregts-van Weezenbeek1, L B Reichman.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11092708

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis.

Authors:  Timothy R Sterling; Harold P Lehmann; Thomas R Frieden
Journal:  BMJ       Date:  2003-03-15

2.  Western Pacific Regional Green Light Committee: progress and way forward.

Authors:  T Islam; B J Marais; N V Nhung; C-Y Chiang; W W Yew; T Yoshiyama; N R Mira; J van den Broek; R Lumb; N Nishikiori; L B Reichman
Journal:  Int J Infect Dis       Date:  2015-03       Impact factor: 3.623

3.  Worldwide emergence of extensively drug-resistant tuberculosis.

Authors:  N Sarita Shah; Abigail Wright; Gill-Han Bai; Lucia Barrera; Fadila Boulahbal; Nuria Martín-Casabona; Francis Drobniewski; Chris Gilpin; Marta Havelková; Rosario Lepe; Richard Lumb; Beverly Metchock; Françoise Portaels; Maria Filomena Rodrigues; Sabine Rüsch-Gerdes; Armand Van Deun; Veronique Vincent; Kayla Laserson; Charles Wells; J Peter Cegielski
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.